My skin is perfect, said no one ever. Real talk: By the time you hit adulthood, your skin has gone through growing pains of its own. Between the ages of 12 and 24, 85% of Americans have at least minor acne, according to the American Academy of Dermatology; another 10.7% will have eczema. Got dry skin? Youre among one in three people who deal with it every day, according to recent research.
In other words, weve all got skin issues. And just as no two people are alike, neither are the skin woes we face, meaning there is no one-treatment-fits-all plan. Each chronic skin condition has its own unique set of symptoms, causes and ways of being managed. Take a look at what the experts have to say about these 10 common skin disordersand how to keep your skin healthy now and in the future.
Leave it to the global pandemic to coin a new derm term: We seen a lot of maskne in the last two years, especially at the height of COVID, due to all the mask-wearing and how it affects the skin, saysDr. George Han, MD, PhD, an associate professor and director of research in the department of dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Lenox Hill Hospital in New York City.
Pandemic or not, says Dr. Han, adult acne is on the rise. We have women who never had acne as kids coming in as new patients at 30 years old, he says, adding that the reason for this increase is not clear.
The condition occurs when hair follicles become clogged with oil and dead skin cells, leading to pimples, and to a lesser extent blackheads and whiteheads, according to the Mayo Clinic. Acne can occur on your face, chestand back, among other placesin the case of cystic acne, pimple-like bumps form under the skin surface.
We dont understand exactly why acne happens, however, we know that it is driven by hormones, diet and stress, saysDr. Joshua Zeichner, MD, an associate professor of dermatology and the director of cosmetic and clinical research at Mount Sinai Hospital in New York City.
Over-the-counter topical medications are the first line of defense with acne and can be effective in clearing your skin. Benzoyl peroxide is perhaps the most effective ingredient to treat angry pimples, Dr. Zeichner says. Look for formulations with 2.5% benzoyl peroxide, which studies show to be as effective as higher concentrations but with less skin irritation.
Meanwhile, topical retinoids act like pipe cleaners to keep the pores clear, Dr. Zeichner says. I use them in treating my adult acne patients because they also offer collagen-stimulating benefits to address aging skin. Products containing salicylic acid may also help, he says: This ingredient is a type of beta hydroxy acid that removes excess oil and dead cells from the surface of the skin to help dry out pimples.
If youve given these remedies a try and your acne stubbornly persists, its time to call in the reinforcements. If they are not doing the trick after one to two months, I recommend speaking to a dermatologist for professional recommendations and to consider an oral medication, says Dr. Zeichner. In adult women, we use hormonal therapies like birth control pills or spironolactone to address the hormonal impact on oil glands.
Related: Do Pimple Patches Actually Work?
If youre thinking, I didnt know dry skin was an actual condition, were with you. But theres the dish-soap-dried-out-my-hands dry skin, and then theres the clinical sort. Known as xerosis cutis, clinically dry skin can cause cracking, bleeding, itching and irritation. The condition frequently affects older people and is made worse by dry heat during winter months.
Dry skin can also be caused by another underlying condition, such as eczema or kidney disease, according to the American Academy of Dermatology (AAD). Certain medications can contribute to dry skin as well.
Treatment for dry skin starts with lifestyle changes. Follow these tips from the AAD:
In severe cases, your dermatologist might also prescribe a steroid for short-term use to calm any inflammation thats making itching or cracks in your skin worse.
Unless youve been living under a rock (pun intended), you know all about alopecia as it pertains to Jada Pinkett Smith, the Oscars and that infamous Chris Rock slap. In a nutshell, alopecia refers to hair loss. There are a few types of alopecia; alopecia areata is the most commonan autoimmune condition in which the immune system attacks hair follicles on the face, head and sometimes other areas of the body, causing hair to fall out.
Alopecia can occur in both men and women and people of any race and age, although it typically appears for the first time when people are in their 20s, 30s and 40s, per the National Institutes of Health. About 6.8 million Americans have alopecia areata, with a lifetime occurrence around 2%, according to the National Alopecia Areata Foundation.
Depending on your age, location of hair loss and extent of baldness, your doctor may talk with you about the following options to help stimulate hair growth, per the American Academy of Dermatology:
Other options include wigs, transplants or scalp prosthesis, or going the opposite route and shaving your head.
Related: Best Skincare Routine for Morning and Night
Even the word sounds itchyand with eczema, your skin usually is. We talk about eczema as the itch that rashespeople feel itchy and before their eyes, a rash starts to appear, says Dr. Han. That rash typically looks like tiny red bumps clustered together.
While the condition has no single cause, there is often a family history of asthma and allergies associated with the condition. (The condition itself is tied to genetics: If one of your parents has eczema, your risk of developing it jumps two- to three-fold, according to research in the Journal of Pediatrics.) Other triggers for the condition include smoking, stress, dry skin and hormonal fluctuations, among others.
Eczema is a condition where the skin barrier is not functioning as well as it should be, says Dr. Zeichner. In eczema, the microbiome, or collection of microorganisms that live on the skin surface, is disrupted. This leads to loss of hydration and inflammation in the skin.
Atopic dermatitis is the condition most people mean when they refer to eczemathe terms are used interchangeably. But there are several other types of the condition, according to the Cleveland Clinic, including contact dermatitis (caused by direct skin contact with an irritant); dyshidrotic eczema (blisters on hands and feet); hand eczema (symptoms are limited to your hands); neurodermatitis (patches on skin are thicker); nummular eczema (characterized by larger welts on your skin); and stasis dermatitis (caused by faulty veins that leak fluid).
The goal of treatment is to repair the skin barrier with moisturizers, says Dr. Zeichner. We also want to reduce inflammation in the skin with over-the-counter anti-inflammatories or topical or systemic medication by prescription. Treatments for eczema range from DIY therapies (warm baths, baking soda and thick moisturizers) to medical intervention. Your doctor may talk with you about calcineurin, Janus kinase and PDE4 inhibitors, or biologics, all of which work by blocking certain proteins in the body that turn on skin inflammation.
So that waseczema. The skin condition it is most commonly confused with is psoriasis. If you look at old medical textbooks, youll see that we used to distinguish between the two by saying that eczema means you have itchy skin and psoriasis doesnt itch, says Dr. Han. But in the past few decades that has been turned on its head and we now know psoriasis also itches.
In fact, he says, 80% to 90% of psoriasis patients cite itching as a primary symptom. So what makes psoriasis different than eczema? Mainly, how and where the disease appears on the body. The classic description of a psoriasis lesion is thick scaly skin on top of a plaque, says Dr. Han. It tends to be a red area thats relatively clearly cut off from the surrounding skin. Whereas with eczema, you have small red bumps in red patches on skin.
(scroll to keep reading)
While plaque psoriasis is the most common form of this condition, there are other types of psoriasis, including nail, scalp, guttate, inverse, pustular and erythrodermic psoriasis. In all cases, the psoriasis is caused by skin cell turnover that occurs too quickly. The process usually takes 30 days, but in people with psoriasis, cell turnover happens in three days, says Dr. Han. The dead skin cells pile up, leading to the conditions telltale plaques.
Treatments for psoriasis range from topical creams like retinoids to systemic medications, and which you use depends largely on the severity of your condition. In cases where your symptoms are very mild, you might even try home remedies for psoriasis, including moisturizers that contain salicylic acid to help exfoliate the plaques, essential oils (the benefits of these are questionable), mindfulness techniques and various foods to reduce skin inflammation. (Skip the processed foods, which make inflammation worse, according to research in the Journal of Investigative Dermatology.)
For moderate to severe psoriasis, your doctor will likely talk with you about drugs called biologics, which work by targeting the proteins in your body responsible for causing inflammation in your skin. Biologics are usually given as injections.
Related: Dermatologist-Approved Skincare Routine for Oily Skin
Rosacea can look a lot like acne but typically affects older patients as opposed to teens, says Alok Vij, M.D., a dermatologist at the Cleveland Clinic in Ohio. Rosacea can have a few components: broken blood vessels on the skin surface, pustules like acne but not blackheads and thickening of the sebaceous skin. (Picture W.C. Fields with thick skin on his nose, he suggests.)
So, how is rosacea treated? We start by classifying the severity of the disease, says Dr. Vij. If its mild, well use topical anti-inflammatory creams or antibiotics for pustular rosacea. Laser therapy may help reduce redness from blood vessels and there is some evidence that oral vitamin A therapy is helpful.
Rosacea treatment may take four weeks to see improvement because that's the length of a full skin cycle, he adds. In the meantime, many over-the-counter products and cosmetics can lessen the red appearance.
Unlike most of the common and chronic skin conditions that are marked by increased plaques, bumps or redness, the disorder vitiligo is characterized by whats missing: Namely, skin color. Vitiligo is an autoimmune condition in which your own antibodies attack cells called melanocytes in your body, says Nada Elbuluk, M.D., a clinical associate professor of dermatology at the Keck School of Medicine and director of the USC Skin of Color Center and Pigmentary Disorders Clinic at the University of Southern California in Los Angeles. These cells create melanin, which is what gives skin its color, so once they are affected, those areas of skin develop white patches.
Although scientists are still exploring the causes of vitiligo, the current thinking is that some people are genetically predisposed to the condition. There are two things that need to happen for vitiligo to occur, says Dr. Elbuluk. First, you have the genetics for it, and second, there is some sort of eventmaybe a sunburn or skin scrape or even stressthat triggers the onset of vitiligo.
The psychological impact of vitiligo can be severe: In a review of dozens of studies, a report in the American Journal of Clinical Dermatology found that 62% of people with vitiligo also suffer from depression while 68% struggle with anxiety. People with vitiligo start to self-isolate or feel uncomfortable in social situations, says Dr. Elbuluk. The emotional symptoms of the disease are very concerning.
Treatment for vitiligo varies depending on which parts and how much of the body is affected, and may include phototherapy, laser therapy, topical steroids, oral medication and surgery. Some people, though, may choose not to treat vitiligo at all. Celebrities like model Winnie Harlow have built their career celebrating their unique skin appearance.
If youve ever nicked yourself shaving, only to discover an inflamed red bump in the spot the following day, thats folliculitis. Sometimes referred to as fungal acne, the condition is marked by infected or inflamed bumps on the skin that can look like acne at first, according to the Cleveland Clinic. There are different types of folliculitis, named either for the type of bacteria that has caused the infection or the severity and location of the skin symptoms. (You can develop folliculitis anywhere and everywhere, including your butt, chestand chin.)
Folliculitis is a very common and benign condition that refers to little pimples that occur any place where there are hair follicles on your body, says Dr. Vij. You can get it on your face, thighs, back of armsjust about anywhere. Because symptoms (inflamed bumps) are typically mild, we tend to use fewer aggressive treatments, says Dr. Vij. These might include benzoyl peroxide washes and topical antibiotics, as well as warm compresses and anti-itch creams.
Related: Best Sunscreens for Sensitive Skin
Sweat much? If so, you might be among the one in 20 people in the U.S. who have hyperhidrosis, a skin condition characterized by excessive perspiration (the exact number of folks with hyperhidrosis is unknown and estimates range from one in 50 people to closer to one in 10, per the Cleveland Clinic.
We all sweat sometimesits how our body cools itself, after all. But in people with hyperhidrosis, not only is sweating excessive, it can happen at random times, for no apparent reason, when youre not even stressed. It is disruptive at best and a self-confidence crusher at its worst.
How can you tell the difference between a heavy sweater and one with a clinical disorder? The Cleveland Clinic list these symptoms of hyperhidrosis:
There are two types of hyperhidrosis: focal (also called primary) which results from a genetic mutation and generalized (also called secondary) which results from another condition or medication you may be taking.
Based on the severity of your sweating, your doctor may treat your hyperhidrosis with anything from clinical-grade antiperspirants to iontophoresisthis at-home device zaps your skin with a mild current to temporarily shut down your sweat glands, according to the American Academy of Dermatology. Other treatments include Botox injections, oral medication and even surgery to remove the sweat glands.
Hidradenitis is a condition where cysts, nodules and scars typically develop in areas like the underarms, groin and under the breasts, says Dr. Zeichner. We dont understand exactly why it happens, but we know that it is caused by blockages within sweat glands.
Risk factors for developing the condition (which can appear as bumps and blackheads on the skin surface) include family history, smoking and obesity.
Hidradenitis suppurativa is associated with other severe acne-like conditions, which are collectively known as the follicular occlusion tetrad, Dr. Zeichner says. Hidradenitis suppurativa goes through flares and remissions, but most lesions never completely clear, he adds. While medications can help keep symptoms under control, currently there is no cure.
Lifestyle modifications can help though. These include regular cleaning of the under-skin pimples with surgical-grade, antimicrobial cleansers; a healthy diet and exercise to maintain a proper body weight; and quitting smoking.
In mild cases, topical medications offer some help, says Dr. Zeichner. Cortisone injections to reduce inflammation are useful. Larger abscesses may be drained. In severe cases, plastic surgeons may remove the glands in the affected areas altogether and replace the skin with a graft.
As the disease progresses, systemic medications may be needed as well, including a biologic medication (Humira) that is FDA-approved to address the underlying inflammatory response that makes symptoms worse.
And there you have it: The main chronic skin conditions that can mess with your daily mojo. Theyre more common than most people realizeespecially when you add them all together. So if your skin is itching and you havent visited a patch of poison ivy lately, talk with your dermatologist about whats going on. If you do have one of these chronic skin disorders, treating it early will help you get back to your regularly scheduled life.
Next up: These Top TikTok Skincare Hacks Actually Work
Read more here:
These Are the 10 Most Common Chronic Skin Conditionsand the Most Important Facts to Know About Them - Parade Magazine
- Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment ... - Dermatology Times - April 18th, 2024 [April 18th, 2024]
- Psoriasis Patients with Arthralgia At Increased Risk of Psoriatic Arthritis Development - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Diagnosing Psoriatic Arthritis for the Dermatologist: Guidance From the Experts - Medscape - April 18th, 2024 [April 18th, 2024]
- Secukinumab 300 mg May Improve PsA or Active Psoriasis More Than 150 mg - MD Magazine - April 18th, 2024 [April 18th, 2024]
- The Impact of Pediatric Plaque Psoriasis on Children and Caregivers - HMP Global Learning Network - April 18th, 2024 [April 18th, 2024]
- Guselkumab Led to Improvements Over Several Psoriatic Arthritis Disease Domains - MD Magazine - April 18th, 2024 [April 18th, 2024]
- Dual Diagnosing and Managing Psoriasis and Psoriatic Arthritis - The Dermatologist - April 18th, 2024 [April 18th, 2024]
- Etanercept Effective for Psoriasis, Rheumatic Disease Among Patients Extending Treatment After 12-Weeks - MD Magazine - February 9th, 2024 [February 9th, 2024]
- High Response Rates in Psoriasis With Oral IL-23 Inhibitor - Medpage Today - February 9th, 2024 [February 9th, 2024]
- Psoriasis and eczema have complex causes and consequences that researchers are seeking to uncover - Medical Xpress - February 9th, 2024 [February 9th, 2024]
- New Hope in Treatment of Plaque Psoriasis: Study Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- No Difference in Psoriasis Immune Response Despite Switch Between AVT02, Adalimumab - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Oral IL-23 Receptor Antagonist Peptide Effective in PASI Reduction for Psoriasis - MD Magazine - February 9th, 2024 [February 9th, 2024]
- Breakthrough in Psoriasis Treatment: JNJ-77242113 Shows Promising Results - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from Phase II Trial of Oral Interleukin Inhibitor for Psoriasis Treatment - Medriva - February 9th, 2024 [February 9th, 2024]
- Promising Results from the FRONTIER 1 Trial - An Exploration of JNJ-77242113 in the Treatment of Moderate-to ... - Medriva - February 9th, 2024 [February 9th, 2024]
- Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva - February 9th, 2024 [February 9th, 2024]
- Rising Cost of Stelara: Impact on Patients and Johnson & Johnson's Market Performance - Medriva - February 9th, 2024 [February 9th, 2024]
- Global Psoriatic Arthritis (PsA) Treatment Market to achieve a remarkable US$ 15.6 Billion by 2028, - PharmiWeb.com - February 9th, 2024 [February 9th, 2024]
- Tremfya potential highlighted by industry analyst GlobalData - The Pharma Letter - May 31st, 2023 [May 31st, 2023]
- Stress Leads to Increased Risk of Depression, Anxiety for Psoriasis ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Janssen Announces Positive Results From Guselkumab Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Early Intervention with Secukinumab May Be Effective for Patients ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- VEGF-A Inhibition Downregulates Blood Vessel Area in Psoriasis - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Scratching the itch, Lynk Pharmaceuticals trialling ointment for ... - OutSourcing-Pharma.com - May 31st, 2023 [May 31st, 2023]
- Brepocitinib More Efficacious Than Placebo in Long-Term Psoriatic ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- For Patients With Birthmarks, Psychosocial Interventions Improved ... - Dermatology Times - May 31st, 2023 [May 31st, 2023]
- Robert Hariri, MD: Natural Killer Cell Therapy Shows Remarkable ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Nalbuphine ER Tablets Show Promise as Cough Therapy in ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- Benefit of Empagliflozin in HFpEF Consistent Regardless of Diuretic ... - MD Magazine - May 31st, 2023 [May 31st, 2023]
- selectION reports results from SAD stage of si-544 Phase Ib trial - Clinical Trials Arena - May 31st, 2023 [May 31st, 2023]
- No Link Observed Between Gastrointestinal Tract Surgery and New ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Lynk doses first cohort in Phase Ib trial of psoriasis therapy - Clinical Trials Arena - May 30th, 2023 [May 30th, 2023]
- Metabolic Inflammation Contributes to Depression in Psoriatic Disease - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Encouraging Diversity and Inclusion for Patients With Psoriatic ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- The Weekly Roundup: May 22-26 - Dermatology Times - May 30th, 2023 [May 30th, 2023]
- Pediatric Psoriasis Market: A Study of the Industry's Key Applications ... - The Navajo Post - May 30th, 2023 [May 30th, 2023]
- Phototherapy Lamps Market are set to witness a CAGR of 5.8 ... - Digital Journal - May 30th, 2023 [May 30th, 2023]
- Celltrion seeks approval for Stelara biosimilar in EU - The Investor - May 30th, 2023 [May 30th, 2023]
- Peter Marinkovich, MD: FDA Approval of B-VEC Gene Therapy for ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Nick Stucky, MD, Phd: Implications for Media Influence on Minoxidil ... - MD Magazine - May 30th, 2023 [May 30th, 2023]
- Tildrakizumab Linked With HRQOL Improvement in Psoriasis in a Real-World Setting - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Clinical Utility of Deucravacitinib for the Management of Moderate to ... - Dove Medical Press - May 18th, 2023 [May 18th, 2023]
- Covid-19 and Psoriasis: Is there a link? - Dunya News - May 18th, 2023 [May 18th, 2023]
- Improvement Needed in Study Interventions to Better Skin Self ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- Reviva Pharmaceuticals Announces Intent to File an IND for Brilaroxazine in Psoriasis After Promising Preclinical Data - Marketscreener.com - May 18th, 2023 [May 18th, 2023]
- Adam Friedman, MD: Addressing Disparities in Care for Patients ... - MD Magazine - May 18th, 2023 [May 18th, 2023]
- Early-Infancy Meningitis Infection Linked With Increased Risk of ... - AJMC.com Managed Markets Network - May 18th, 2023 [May 18th, 2023]
- NOVN: Counting Down to PDUFA - Yahoo Finance - May 18th, 2023 [May 18th, 2023]
- Psoriatic Arthritis (PsA) Treatment Market is likely to register CAGR ... - Future Market Insights - May 18th, 2023 [May 18th, 2023]
- New campaign raises awareness of topical steroid withdrawal - Professional Beauty - May 18th, 2023 [May 18th, 2023]
- MoonLake Immunotherapeutics completes patient enrollment and randomization ahead of schedule in a Phase 2 trial of the Nanobody sonelokimab in... - February 2nd, 2023 [February 2nd, 2023]
- EVELO BIOSCIENCES, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Other Events (form 8-K) -... - February 2nd, 2023 [February 2nd, 2023]
- 12 Ways to Treat Psoriasis at Home - Healthline - January 22nd, 2023 [January 22nd, 2023]
- DTC Advertising Of Prescription Drugs In The U.S. Often Promotes Products With Comparatively Low Therapeutic Value - Forbes - January 19th, 2023 [January 19th, 2023]
- Types of Psoriasis: Pictures, Symptoms and Treatments - Healthline - December 18th, 2022 [December 18th, 2022]
- Psoriasis Pathogenesis and Treatment - PMC - PubMed Central (PMC) - November 23rd, 2022 [November 23rd, 2022]
- Drug-Provoked Psoriasis: Is It Drug Induced or Drug Aggravated? - November 23rd, 2022 [November 23rd, 2022]
- Im a Dermatologist and These 7 Things Could Be Making Your Psoriasis Worse - Well+Good - October 19th, 2022 [October 19th, 2022]
- 'Worst time of the year for me to be covered in scabs': Amber Heard's Alleged Ex Cara Delevingne Revealed Her Psoriasis Struggle Made Kate Moss Scream... - October 19th, 2022 [October 19th, 2022]
- Psoriasis: What It Is, Symptoms, Causes, Types & Treatment - October 17th, 2022 [October 17th, 2022]
- What is psoriasis and which foods ease symptoms? - Evening Standard - October 17th, 2022 [October 17th, 2022]
- Chronic inflammatory diseases: what they are - Emergency Live International - October 17th, 2022 [October 17th, 2022]
- How remote care can deliver a step change in treatment for inflammatory skin conditions - PoliticsHome - October 17th, 2022 [October 17th, 2022]
- Probiotics Supplementation may Improve Symptoms of Hyperuricemia and Gout - Rheumatology Network - October 15th, 2022 [October 15th, 2022]
- Psoriasis Pathogenesis and Treatment - PubMed - October 2nd, 2022 [October 2nd, 2022]
- Best and Worst Drinks for Psoriasis - Everyday Health - October 2nd, 2022 [October 2nd, 2022]
- Survey Addresses Concerns Regarding Reproductive Healthcare Communication in Women with RA, PsA - Rheumatology Network - October 2nd, 2022 [October 2nd, 2022]
- Psoriasis Types, Symptoms & Causes | NIAMS - September 29th, 2022 [September 29th, 2022]
- What Is Psoriasis And Can It Be Treated? - Forbes - September 29th, 2022 [September 29th, 2022]
- Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings - MD Magazine - September 29th, 2022 [September 29th, 2022]
- Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis - Business Wire - September 29th, 2022 [September 29th, 2022]
- 15 Items That Will Make Your Life With Psoriatic Arthritis Easier - BlackDoctor.Org - September 29th, 2022 [September 29th, 2022]
- Types of Psoriasis and Their Effects on the Immune System - Cureus - September 27th, 2022 [September 27th, 2022]
- MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody sonelokimab in patients with active psoriatic arthritis - BioSpace - September 27th, 2022 [September 27th, 2022]
- How diversity and inclusion continues to be incorporated in dermatology - PMLiVE - September 27th, 2022 [September 27th, 2022]
- Arcutis Announces Topline Results From ARRECTOR Pivotal Phase 3 Trial Of Roflumilast Foam 0.3% In Scalp A - Benzinga - September 27th, 2022 [September 27th, 2022]
- Psoriasis Treatment Market Size to Hit USD 51.24 Bn by 2030 - GlobeNewswire - August 15th, 2022 [August 15th, 2022]
- Ventyx Sees Initiation Of Mid-Stage Psoriasis Study In Q4 2022 Following Positive Data From Initial-Stage - Benzinga - August 15th, 2022 [August 15th, 2022]
- Woman, 29, Slams Bullies Who 'Giggle And Whisper' At Her Unsightly Psoriasis Sores And Scabs, Leaving Her Depressed And 'Struggling To Walk' -... - August 15th, 2022 [August 15th, 2022]